TrialIn vivo (Athens, Greece)

A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral Clearance Outcomes.

Duong T Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.